Merrimack Pharmaceuticals Inc (NASDAQ:MACK) share price plunged -4.98% or -0.16 points to reach at $3.05 during previous trading session. The stock’s price fluctuated within the range of $3.03 – $3.24 during previous trading session. A total of 4,016,978 shares exchanged hands, whereas the company’s average trading volume stands at 4.10M shares. Merrimack Pharmaceuticals Inc (NASDAQ:MACK) has a market capitalization of $388.07M and most recently 129.62M outstanding shares have been calculated.
In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.
Relative strength index (RSI-14) for Merrimack Pharmaceuticals Inc (NASDAQ:MACK) is at 19.04.
According to sentiments of 3 analysts the mean estimates of short term price target for the company’s stock is marked at $9.00. The most optimistic analyst sees the stock reaching $15.00 while the most conventional predicts the target price at $5.00.
The consensus mean EPS for the current quarter is at $-0.21 derived from a total of 4 estimates. According to analysts minimum EPS for the current quarter is expected at $-0.35 and can go high up to $-0.14. However a year ago during same quarter Merrimack Pharmaceuticals Inc (NASDAQ:MACK) reported $-0.41 EPS.
For the upcoming quarter, initial predictions are anticipating that the company will post earnings of $-0.03 per share according to consensus of 2 analysts.
According to sentiments of 4 analysts the company is expected to report revenues of $61.07M for the current quarter. Bearish revenue estimates established at $19M while the bullish revenue forecast has been figured out at $104.1M.
In terms of Buy/Sell recommendations, analysts have a consensus rating of 2.50 on the shares of Merrimack Pharmaceuticals Inc (NASDAQ:MACK). Out of rating recommendations 1 have given the stock a Buy while 0 recommend the stock as Outperform. 3 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.
On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance. Merrimack Pharmaceuticals Inc (NASDAQ:MACK)’s distance from 20 day simple moving average is -26.37% whereas its distance from 50 day simple moving average is -40.51% along with -47.17% distance from 200 day simple moving average.
Important factors to consider when evaluating a stock’s current and future value are the 52 week price high and low levels. Merrimack Pharmaceuticals Inc (NASDAQ:MACK) hit its 52-week high price on 04/07/16, and 52-week low price on 01/17/17.
When we have a peek on stock’s historical trends we come to know that, the stock has slipped -16.89% in the past one week and plunged -41.46% during previous one month drive, the stock went down -38.51% during past quarter. In the last six months the stock’s performance fell -43.41% while yearly performance of the company fell -50.49%. The company’s year to date (YTD) performance is at -25.25%.
While taking a glance at financials, we can look at a number of key indicators. Merrimack Pharmaceuticals Inc (NASDAQ:MACK) has a Return on Assets (ROA) of -96.00%. The company currently has a Return on Equity (ROE) of 80.60%. Average true range (ATR-14) of the company sets at 0.32, along with its weekly and monthly volatility of 6.94%, 7.79% respectively. Beta value of the stock stands at 1.91.
The company’s quick ratio for most recent quarter is 0.80 along with current ratio for most recent quarter of 1.00.